Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2088517 | 0.86 | KDM4E (0.50) | KDM4EALDH1A1POLBHTTKMT2A | |
| SCHEMBL2088116 | 0.79 | SYK (0.65) | KDM4EALDH1A1POLBTSHR | |
| SCHEMBL4042949 | 0.79 | SLC29A1 (0.50) | POLBKMT2ATSHRMEN1 | |
| SCHEMBL4040473 | 0.79 | KDM4E (0.62) | KDM4EALDH1A1POLBKMT2ATDP1 | |
| SCHEMBL4036604 | 0.73 | CYP2D6 (0.60) | KDM4EALDH1A1TDP1TSHR | |
| SCHEMBL12845569 | 0.72 | KDM4E (0.49) | KDM4EALDH1A1POLBHTTKMT2A | |
| SCHEMBL12781737 | 0.71 | SIGMAR1 (0.51) | KDM4EALDH1A1POLBHTTKMT2A | |
| SCHEMBL6992013 | 0.71 | POLB (0.68) | ALDH1A1POLBKMT2ATDP1MEN1 | |
| SCHEMBL12435658 | 0.70 | SYK (0.77) | POLBKMT2ATSHRMEN1 | |
| SCHEMBL3859145 | 0.70 | KDM4E (0.52) | KDM4EALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1562589-B1 | DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES | VERTEX PHARMA (US) | 2009-01-07 | — | — | EP | disclosed |